Article Information
- Received November 30, 1998
- Revision received April 15, 1999
- Accepted April 16, 1999
- First published July 1, 1999.
- Version of record published July 1, 1999.
Author Information
Author contributions
Disclosures
- Received November 30, 1998.
- Revision received April 15, 1999.
- Accepted April 16, 1999.
We thank Drs. David J. Anderson, Fred H. Gage, Steve Heinemann, Patrick Hogan, Bruce Koch, Steve Matsumoto, Mahendra S. Rao, Jacqueline A. M. Smith, A. Neil Verity, and John N. Wood for suggestions during the course of this work and Drs. David W. Anderson and Alan Lewis for encouragement. We also thank Michael Housley, Hoang Le, James Leisten, Nandita Patnaik, and Gilbert Ramirez for outstanding technical support and Nathan Eller for expert graphics assistance.
Correspondence should be addressed to Dr. Heather K. Raymon, Signal Pharmaceuticals Incorporated, 5555 Oberlin Drive, Suite 100, San Diego, CA 92121.
Dr. Johnson’s present address: DURECT Corporation, 10240 Bubb Road, Cupertino, CA 95014.
Dr. Sah’s present address: Biogen, 14 Cambridge Center, Cambridge, MA 02142.
Online Impact